Tips on the Policy of Medical Insurance for Major Diseases in Jinhua City
Release time:
2020-08-14
Jinhua City critical illness medical insurance policy tips
1, Who should participate in critical illness insurance?
Jinhua City basic medical insurance for employees and basic medical insurance for urban and rural residents should participate in critical illness insurance, not to participate in the basic medical insurance, not to participate in the basic medical insurance alone.
The critical illness insurance benefits are consistent with the effective time of the basic medical insurance benefits, and if the basic medical insurance benefits are interrupted or terminated, the critical illness insurance benefits are interrupted or terminated at the same time.
2, Major illness insurance premium composition
Major illness insurance premium consists of basic premium and optional premium.
Basic premium. According to the government, the unit financing ratio 60% , the insured individual contribution ratio 40% to raise, and basic medical insurance premiums combined. The basic premium for 2018 is determined to be 50 yuan per person.
Option to pay premiums. The establishment of a major illness insurance optional premium program is to improve the ability to protect major illness insurance. The optional premium for each ,100 yuan is paid by individuals within the specified time, up to ,3 .
3, What are the benefits after taking part in serious illness insurance? If
fails to pay the optional premium or has been paid for less than three consecutive years, for the compliance medical expenses above the critical illness insurance minimum payment standard (2018 is 1.9 yuan), the critical illness insurance will be reimbursed 75% , with a maximum reimbursement of 40 yuan.
For those who have paid the premium for three consecutive years and 1 consecutive years, the reasonable medical expenses above the minimum payment standard (1.9 yuan in 2018 ) will be reimbursed for 75% for serious illness insurance, with a maximum reimbursement of 60 yuan; for those who choose to pay 2 for three consecutive years, the reasonable medical expenses above the minimum payment standard (1 yuan in 2018 ) will be reimbursed 80% for serious illness insurance, and the maximum reimbursement will be 80 yuan. For three consecutive years, choose to pay 3 copies, reasonable medical expenses above the minimum payment standard (yuan in 2018 ) will be reimbursed for.85% of by serious illness insurance, and the reimbursement amount will not be capped.
4, Poor People's Serious Illness Protection Inclination Mechanism
For the extremely poor and the minimum living security family members, all counties (cities, districts) can provide subsidies through medical assistance for the following compliant medical expenses. The specific personnel shall be determined by the civil affairs department.
For poor people and family members with minimum living security, each county (city, district) shall fully subsidize and pay elective premiums, and for marginal family members with minimum living security and other special difficulties stipulated by the people's government at or above the county level, at least elective premiums shall be paid with full subsidies. The specific number of subsidies shall be determined by each county (city, district).
Other people with special difficulties in Jinhua city refer to the severely disabled with certificates and the mentally ill with certificates, and the number of premium paid is determined to be 1 .
5, optional premium payment method
optional premium payment is consistent with the basic premium collection period, and the number of optional premium payments is selected by the individual during the collection period. Urban insured persons can go to urban 7 banks (ICBC, Bank of China, Agricultural Bank of China, China Construction Bank, Jinhua Bank, Chengtai Bank, Postal Savings Bank) to sign agreements to withhold and pay premiums from their contracted bank accounts. 2018 2# November and September, urban insured persons can also pay optional premiums to the financial public payment platform through Jinhua People's Society APP . Other counties (cities) insured personnel according to the county (city) social security agencies to arrange the way to pay.. If the optional premium is not paid within the collection period, it is allowed to pay in the year of serious illness insurance, and the corresponding treatment of the optional premium in this year is not enjoyed, and the payment period can be calculated continuously. Cross-year, as interrupted, again choose to pay, the payment period recalculated.
This year's optional premium collection period is determined to be 2018 1# December 8 to 5 .
Jinhua City Original Large Supplementary Medical Insurance and Major Illicit Disease Insurance Policy Connection
2017 For insured persons who have paid the original large supplementary medical insurance fee, if the number does not exceed 3 , the number of optional premium number for 2018 shall be determined according to the original number, if it is necessary to increase the number of copies, a new entrustment withholding agreement shall be signed. If it exceeds 3 copies, it shall be calculated as 3 copies.
The amount of 50% (hereinafter referred to as the amount of 50% ) of the original large supplementary medical insurance fees paid in 2017 is used to offset the premium paid by 2018 , and the shortfall is made up within the prescribed payment period. If the amount of 50% is more than ,300 yuan, will not be refunded in 2018 . If the treatment of the original large supplementary medical insurance system is higher than that of the serious illness insurance system, the settlement shall be made according to the original large supplementary medical insurance system.
Preferential Policies Remind
Year May Those who pay the optional premium before the end of June will be directly entitled to the treatment of paying for three consecutive years.
2018 5 March 31 , inpatient medical expenses settled before the optional premium payment (2018 1 September 1 to 2018 5 May 31 Sunrise Hospital) can be re-settled and enjoy the corresponding serious illness insurance optional payment treatment.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31